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Abstract  
Introduction: Myeloid sarcoma is a rare extramedullary manifestation of Acute myeloid 
leukemia(AML). Primary involvement of the biliary tract with myeloid sarcoma is very rare.  
Case Presentation: A 29 year old man presented with obstructive jaundice. Magnetic Resonance 
cholangiopancreatography showed intrahepatic biliary radicle dilatation involving both lobes of 
liver. There was a mass lesion involving the common hepatic duct, cystic duct and proximal 
common bile duct. He underwent laparotomy and excision of  the mass,  cholecystectomy and  
hepatojejunostomy for a mistaken diagnosis of cholangiocarcinoma.  The histopathology was 
suggestive of myeloid sarcoma. Subsequent bone marrow examination showed AML.  He received 
chemotherapy for AML and continues to be in remission at 2 years.  
Conclusion: Isolated biliary involvement by myeloid  sarcoma is extremely rare and may be 
misdiagnosed as  as cholangitis or cholecystitis or as cholangiocarcinoma. Biliary myeloid  
sarcoma should also be included in the differential diagnosis of patients with obstructive jaundice 
and investigated for AML. 
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Introduction 
Primary hematological malignancies of the 
extrahepatic biliary tracts are rare. Myeloid 
sarcoma (MS) also known as granulocytic sarcoma 
or chloroma is a rare extramedullary tumor 
composed of myeloid progenitor cells. Primary 
involvement of the biliary tract with MS is very 
rare. We present the case of a 29 year old man 
with Acute myeloid leukemia (AML) who 
presented with obstructive jaundice caused by  
myeloid sarcoma of biliary ducts. 
Case presentation 
A 29 year old man presented to us following 
laparotomy for suspected cholangiocarcinoma 
causing obstructive jaundice. Earlier he had 
presented to the local hospital with abdominal 
pain since 5months, jaundice, pruritis, and white 
stools since 2 weeks. On examination he was 
having icterus and hepatomegaly. His 
Haemoglobin(Hb) was 14.3gm%, Total White cell 
count (TC) was 6680/mm3, platelet count was 
3,03,000/ mm3. His total bilirubin was 22.5mg/dl, 
(direct bilirubin 10.8gm/dl), serum glutamic 
oxaloacetic transaminase (SGOT) was 86 U/L, 
serum glutamic-pyruvic transaminase (SGPT) was 
54 U/L, serum alkaline phosphatase (SAP) was 
342 U/L. Viral markers were negative.  
Ultrasonogram of the abdomen showed 
hepatomegaly with thickened gall bladder and 
dilated proximal biliary duct. Computerised 
tomogram of abdomen showed intrahepatic biliary 
radical dilatation. Gall Bladder was filled with 
hyperdense bile/ sludge. Magnetic Resonance 
cholangiopancreatography (MRCP) showed 
intrahepatic biliary radicle dilatation (IHBRD) 
involving both lobes of liver and a mass lesion 
involving the gall bladder, cystic duct, common 
hepatic duct (CHD) and proximal common bile 
duct (CBD) (Fig 1 & 2). Pancreas, spleen and 
kidneys were normal. The radiological picture was 
suggestive of cholangiocarcinoma involving CHD, 
cystic duct and proximal CBD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 3D MRCP showing bilateral IHBRD and an abrupt cut off at the proximal common hepatic duct. CBD, Gall 
Bladder and cystic duct not visualized. 
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Figure 2 Coronal FIESTA FAT SAT showing the hyperintense lesion extending to cystic duct, common 
hepatic duct and CBD from gall bladder with proximal ductal dilatation. 
 
Patent underwent laparotomy and excision of 
the mass, cholecystectomy and ROUX en Y 
anastomosis and hepatojejunostomy. The tumor 
was 4x2 cm involving cystic duct, CHD, proximal 
CBD. Lymphnodes were present in 
hepatoduodenal ligament. Post operatively his 
bilirubin dropped to 6.8mg/dl, direct bilirubin to 
3.3mg/dl.  
Subsequently he presented to our institute 
where his Hb was 10.1 gm%, TC was 5600/mm3, 
and platelet count was 2,44,000/mm3. His 
S.Bilirubin was 2mg/dl, SGOT 38U/dl, SGPT 
24U/dl, SAP 115/dl, and lactate dehydrogenase 
512U/dl. Viral markers were negative. Peripheral 
smear showed normocytic normochromic red cells, 
white cells were predominantly blasts (68%), 
which were peroxidase positive. Bone marrow 
showed sheets of blasts which were positive for 
CD 33 and MPO. Flow cytometry of peripheral 
blood showed the blasts to be positive for CD13, 
CD33, CD64 and CD117 and negative for CD10, 
CD19, CD20, CD3, CD5,CD7, CD34 and HLA 
DR suggestive of Acute myeloid leukemia 
M1/M2.  
The histopathology from the resected specimen 
of bile duct and gall bladder showed a neoplasm 
composed of cells in sheets with moderate 
cytoplasm, round to indended nucleus and 
immature chromatin (Fig.3). Neoplastic cells were 
seen to infiltrate into serosa. These cells were also 
positive for CD33 and MPO suggestive of AML 
infiltrating gall bladder (Fig.4 & 5). Bone marrow 
cytogenetics was normal. He received induction 
chemotherapy with cytosine arabinoside and 
daunomycin and achieved bone marrow remission. 
He was consolidated with high dose cytosine 
arabinoside. He continues to be asymptomatic and 
in remission at 2 years. 
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Figure 3 H&Ex400 Section from gall bladder shows an infiltrating neoplasm. Tumour cells have moderate 
cytoplasm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 CD33x400 Tumour cells are CD33 positive. 
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Figure 5 MPOx400 Tumour cells are MPO positive. 
 
Discussion 
Extramedullary involvement by acute leukemia 
is a rare, but clinically significant finding that 
often produces difficulty in diagnosis and 
therapy. Cholestasis as the initial manifestations 
of acute myeloid leukemia is very rare and 
carries a bad prognosis [1]. Isolated biliary 
involvement by myeloid sarcoma is extremely 
rare and may be misdiagnosed as cholangitis or 
cholecystitis or as cholangiocarcinoma. 
Therefore, biliary myeloid sarcoma should be 
included in the differential diagnosis of patients 
with obstructive jaundice. This disease usually 
arises during the course of AML, and less 
frequently in chronic myelogeneous leukemia 
and other myeloproliferative disorders [2]. The 
most common sites of involvement are the 
periosteum, soft tissue, bone, lymph nodes, and 
skin, but numerous sites have been described [3]. 
Males and females are equally affected, with a 
mean age of 48 years. Myeloid sarcoma occurs 
in only 2 to 8% of AML cases, which are mainly 
of the M2 morphology, although the disease has 
also been associated with other FAB types [4]. It 
occurs either concurrently, following or rarely 
prior to the onset of AML. Cytogenetic 
abnormalities such as t (8;21), blast 
differentiation, cell-surface markers, lack of 
Auer rods, FAB classification (M2, M4 and M5), 
high presenting leukocyte count, and cellular 
immune dysfunction have been associated with 
a higher incidence of extramedullary leukemia 
[5]. 
Neiman et al. reported 61 patients with 
granulocytic sarcoma of which 22% occurred as 
the initial presentation or during the course of 
AML. The most common sites of involvement 
of granulocytic sarcoma were the periosteum, 
soft tissue and bone followed by the lymph 
nodes and skin. However granulocytic sarcoma 
in the biliary tract was rare. Only 4 out of 61 
cases had  gastrointestinal tract involvement 
[2]. A case of isolated biliary granulocytic 
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sarcoma in a 30-yr-old man who presented with 
jaundice, fever, and chill without any evidence 
of leukemia was reported by Chang Ohk Sung et 
al [6]. However, five months after the diagnosis, 
he developed acute myelogenous leukemia with 
multilineage dysplasia and chromosomal 
abnormality. A case of an extramedullary 
myeloid tumor of the gallbladder in 33 year old 
man without leukaemia is also reported [7]. He 
also presented with obstructive jaundice and 
underwent hepatopancreatoduodenectomy like 
our patient. A 34 year old man presented with 
the simultaneous appearance of both blast cells 
in bone marrow and obstructive jaundice [1]. 
Joo Young Lee et al described a patient who 
presented with obstructive jaundice resulting 
from leukemic infiltration of extrahepatic bile 
duct, which improved after endoscopic biliary 
drainage combined with chemotherapy [5]. 
Another patient underwent a right hepatectomy 
for stenosis of extrahepatic bile ducts 
mimicking the presentation of Klatskin tumor 
[8]. Our patient underwent surgery for a 
mistaken diagnosis of cholangiocarcinoma and 
the diagnosis of MS was postoperative. He 
received conventional chemotherapy and is 
alive in remission at 2 years.  
Data on the prognostic significance of MS is 
limited. Byrd et al analysed 84 AML patients 
with t(8:21) and reported that those with 
extramedullary disease had worse survival [9]. 
In a later study of 20 patients with isolated MS 
the presence of cytogenetic abnormalities 
especially in chromosome 8 appeared to confer 
a worse outcome [10]. Although the presence of 
MS is associated with a poor prognosis, the 5 
year survival ranges from 20-30%. Because 
leukemia is a rapidly progressive disease, 
contemporary hepatic dysfunction accompanied 
by jaundice may impair tolerance to a rigorous 
therapy and lessen the probability of survival. 
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